Do We Need Controlled Attenuation Parameter Adjustment for Fibrosis Estimation in Nonalcoholic Fatty Liver Disease Patients?

Hepatology - United States
doi 10.1002/hep.29067
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Dietary Patterns in Relation to Hepatic Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2019English

Nonalcoholic Fatty Liver Disease

Hypertension
Internal Medicine
2020English

Serum Biomarkers for Nonalcoholic Fatty Liver Disease: Are We There Yet?

Hepatology
MedicineHepatology
2016English

Nonalcoholic Fatty Liver Disease With Cirrhosis Increases Familial Risk for Advanced Fibrosis

Hepatology
MedicineHepatology
2018English

Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2002English

Intestinal Microbiota in Patients With Nonalcoholic Fatty Liver Disease

Hepatology
MedicineHepatology
2013English

Nonalcoholic Fatty Liver Disease in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Nonalcoholic Fatty Liver Disease in 2020

Gastroenterology
HepatologyGastroenterology
2020English

Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment With MR Elastography

Radiology
Nuclear MedicineRadiologyImaging
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy